The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
24 04 2020
Historique:
received: 20 01 2020
revised: 07 02 2020
accepted: 05 03 2020
pubmed: 8 3 2020
medline: 2 5 2020
entrez: 8 3 2020
Statut: ppublish

Résumé

Motivated by the rapid spread of coronavirus disease 2019 (COVID-19) in mainland China, we use a global metapopulation disease transmission model to project the impact of travel limitations on the national and international spread of the epidemic. The model is calibrated on the basis of internationally reported cases and shows that, at the start of the travel ban from Wuhan on 23 January 2020, most Chinese cities had already received many infected travelers. The travel quarantine of Wuhan delayed the overall epidemic progression by only 3 to 5 days in mainland China but had a more marked effect on the international scale, where case importations were reduced by nearly 80% until mid-February. Modeling results also indicate that sustained 90% travel restrictions to and from mainland China only modestly affect the epidemic trajectory unless combined with a 50% or higher reduction of transmission in the community.

Identifiants

pubmed: 32144116
pii: science.aba9757
doi: 10.1126/science.aba9757
pmc: PMC7164386
mid: NIHMS1577321
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-400

Subventions

Organisme : NIGMS NIH HHS
ID : U54 GM111274
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Science. 2003 Jun 20;300(5627):1961-6
pubmed: 12766206
Lancet Digit Health. 2020 Apr;2(4):e201-e208
pubmed: 32309796
PLoS Comput Biol. 2013;9(1):e1002803
pubmed: 23341757
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
Euro Surveill. 2020 Jan;25(4):
pubmed: 32019669
Int J Infect Dis. 2020 Mar;92:214-217
pubmed: 32007643
Emerg Infect Dis. 2020 May;26(5):1049-1052
pubmed: 32053479
PLoS One. 2006 Dec 20;1:e20
pubmed: 17183647
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
BMC Med. 2009 Sep 10;7:45
pubmed: 19744314
Science. 2020 Apr 24;368(6489):395-400
pubmed: 32144116
Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4334-E4343
pubmed: 28442561
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21484-9
pubmed: 20018697
Science. 2003 Jun 20;300(5627):1966-70
pubmed: 12766207
PLoS Curr. 2014 Sep 02;6:
pubmed: 25642360
J Comput Sci. 2010 Aug 1;1(3):132-145
pubmed: 21415939

Auteurs

Matteo Chinazzi (M)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Jessica T Davis (JT)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Marco Ajelli (M)

Bruno Kessler Foundation, Trento, Italy.

Corrado Gioannini (C)

ISI Foundation, Turin, Italy.

Stefano Merler (S)

Bruno Kessler Foundation, Trento, Italy.

Ana Pastore Y Piontti (A)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Kunpeng Mu (K)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Luca Rossi (L)

ISI Foundation, Turin, Italy.

Kaiyuan Sun (K)

Fogarty International Center, NIH, Bethesda, MD, USA.

Cécile Viboud (C)

Fogarty International Center, NIH, Bethesda, MD, USA.

Xinyue Xiong (X)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Hongjie Yu (H)

School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.

M Elizabeth Halloran (ME)

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Biostatistics, University of Washington, Seattle, WA, USA.

Ira M Longini (IM)

Department of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA. a.vespignani@northeastern.edu ilongini@ufl.edu.

Alessandro Vespignani (A)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA. a.vespignani@northeastern.edu ilongini@ufl.edu.
ISI Foundation, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH